Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gribio is a specialized biotechnology company based in Beijing that focuses on the development and production of high-quality isotope-labeled compounds and biochemical reagents. The company provides a wide range of products including stable isotope-labeled amino acids, peptides, and small molecules essential for metabolic research, proteomics, and drug discovery. In addition to its product catalog, Gribio offers custom synthesis and contract research services (CRO) to support pharmaceutical and academic researchers globally. By leveraging advanced synthesis technologies, the company enables precise quantification and tracing in complex biological systems, serving as a critical supplier for the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Gribio.